Form 8-K - Current report:
SEC Accession No. 0001297184-24-000055
Filing Date
2024-11-06
Accepted
2024-11-06 16:31:09
Documents
14
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20241106x8k.htm   iXBRL 8-K 44813
2 EX-99.1 amph-20241106xex99d1.htm EX-99.1 747595
  Complete submission text file 0001297184-24-000055.txt   947593

Data Files

Seq Description Document Type Size
3 EX-101.SCH amph-20241106.xsd EX-101.SCH 3499
4 EX-101.LAB amph-20241106_lab.xml EX-101.LAB 15362
5 EX-101.PRE amph-20241106_pre.xml EX-101.PRE 10386
17 EXTRACTED XBRL INSTANCE DOCUMENT amph-20241106x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 241431548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)